Halozyme Therapeutics - Financial and Strategic Analysis Review

Summary

Halozyme Therapeutics - Financial and Strategic Analysis Review

Halozyme Therapeutics, a biopharmaceutical company is engaged in the development and commercialization of products targeting the extracellular matrix for the drug delivery, oncology, dermatology and endocrinology markets. Its products portfolio depends on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes affecting the extracellular matrix. The company's Enhanze technology is a novel drug delivery platform proposed to enhance the absorption and dispersion of biologics. Its products include Cumulase for in vitro fertilization and Hylenex an agent for drug and fluid infusion.

Global Markets Direct's Halozyme Therapeutics - Financial and Strategic Analysis Review is an in-depth business, strategic and financial analysis of Halozyme Therapeutics. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed strategic analysis of the company. This highlights its strengths and weaknesses and the opportunities and threats it faces going forward.

Scope

• Provides key company information for business intelligence needs.
• The company's strengths and weaknesses and areas of development or decline are analyzed. Financial, strategic and operational factors are considered.
• The opportunities open to the company are considered and its growth potential assessed. Competitive or technological threats are highlighted.
• The report contains critical company information - business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
• The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
• Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Reasons to buy

• A quick "one-stop-shop" to understand the company.
• Enhance business/sales activities by understanding customers' businesses better.
• Get detailed information and financial and strategic analysis on companies operating in your industry.
• Identify prospective partners and suppliers - with key data on their businesses and locations.
• Capitalize on competitor's weaknesses and target the market opportunities available to them.
• Compare your company's financial trends with those of your peers / competitors.
• Scout for potential acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Contents

• List of Tables
• List of Figures
  • Halozyme Therapeutics - Key Facts
  • Halozyme Therapeutics - Business Description
  • Halozyme Therapeutics - Major Products and Services
  • Halozyme Therapeutics - History
  • Halozyme Therapeutics - SWOT Analysis
  • SWOT Analysis - Overview
  • Halozyme Therapeutics - Strengths
  • Strength - Proprietary Enhanze Technology
  • Strength - Focused Research and Development Activities
  • Strength - Collaborative Agreements
  • Halozyme Therapeutics - Weaknesses
  • Weakness - Increasing Operating Losses
  • Halozyme Therapeutics - Opportunities
  • Opportunity - Chemophase- Lead Product Candidate
  • Opportunity - Product Pipeline
  • Opportunity - Growing Oncology Treatment Market
  • Opportunity - Rising Healthcare Expenditure in the US
  • Halozyme Therapeutics - Threats
  • Threat - Increasing Competition
  • Threat - Stringent Regulations
  • Threat - Industry Consolidation
  • Threat - Increased Pricing Control
  • Halozyme Therapeutics - Key Competitors
  • Halozyme Therapeutics - Key Employees
  • Halozyme Therapeutics - Key Employee Biographies
  • Halozyme Therapeutics - Locations And Subsidiaries
  • Head Office
  • Halozyme Therapeutics - Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
• Appendix
  • Methodology
  • Ratio Definitions
  • About Global Markets Direct
  • Contact Us
  • Disclaimer
• List of Tables
  • Halozyme Therapeutics, Key Facts
  • Halozyme Therapeutics, Major Products and Services
  • Halozyme Therapeutics, History
  • Halozyme Therapeutics, Key Employees
  • Halozyme Therapeutics, Key Employee Biographies
  • Halozyme Therapeutics, Ratios based on current share price
  • Halozyme Therapeutics, Annual Ratios
  • Halozyme Therapeutics, Interim Ratios
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
• List of Figures
  • Halozyme Therapeutics, Ratio Charts